Costa, V.; De Fine, M.; Carina, V.; Conigliaro, A.; Raimondi, L.; De Luca, A.; Bellavia, D.; Salamanna, F.; Alessandro, R.; Pignatti, G.;
et al. How miR-31-5p and miR-33a-5p Regulates SP1/CX43 Expression in Osteoarthritis Disease: Preliminary Insights. Int. J. Mol. Sci. 2021, 22, 2471.
https://doi.org/10.3390/ijms22052471
AMA Style
Costa V, De Fine M, Carina V, Conigliaro A, Raimondi L, De Luca A, Bellavia D, Salamanna F, Alessandro R, Pignatti G,
et al. How miR-31-5p and miR-33a-5p Regulates SP1/CX43 Expression in Osteoarthritis Disease: Preliminary Insights. International Journal of Molecular Sciences. 2021; 22(5):2471.
https://doi.org/10.3390/ijms22052471
Chicago/Turabian Style
Costa, Viviana, Marcello De Fine, Valeria Carina, Alice Conigliaro, Lavinia Raimondi, Angela De Luca, Daniele Bellavia, Francesca Salamanna, Riccardo Alessandro, Giovanni Pignatti,
and et al. 2021. "How miR-31-5p and miR-33a-5p Regulates SP1/CX43 Expression in Osteoarthritis Disease: Preliminary Insights" International Journal of Molecular Sciences 22, no. 5: 2471.
https://doi.org/10.3390/ijms22052471
APA Style
Costa, V., De Fine, M., Carina, V., Conigliaro, A., Raimondi, L., De Luca, A., Bellavia, D., Salamanna, F., Alessandro, R., Pignatti, G., Fini, M., & Giavaresi, G.
(2021). How miR-31-5p and miR-33a-5p Regulates SP1/CX43 Expression in Osteoarthritis Disease: Preliminary Insights. International Journal of Molecular Sciences, 22(5), 2471.
https://doi.org/10.3390/ijms22052471